Article

T Cell-Signaling Network Analysis Reveals Distinct Differences between CD28 and CD2 Costimulation Responses in Various Subsets and in the MAPK Pathway between Resting and Activated Regulatory T Cells

Center for Molecular Medicine, Nordic European Molecular Biology Laboratory Partnership, University of Oslo, N-0318 Oslo, Norway.
The Journal of Immunology (Impact Factor: 5.36). 11/2011; 187(10):5233-45. DOI: 10.4049/jimmunol.1101804
Source: PubMed

ABSTRACT To uncover signaling system differences between T cell stimuli and T cell subsets, phosphorylation status of 18 signaling proteins at six different time points following TCR triggering and CD28/CD2 costimulation was examined in human T cell subsets by phospho-epitope-specific flow cytometry of fluorescent cell barcoded samples, thereby providing a high-resolution signaling map. Compared with effector/memory T cells, naive T cells displayed stronger activation of proximal signaling molecules after TCR triggering alone. Conversely, distal phosphorylation events, like pErk and pS6-ribosomal protein, were stronger in effector/memory subsets. CD28 costimulation specifically induced signaling necessary for proper NF-κB activation, whereas CD2 signaled more strongly to S6-ribosomal protein. Analysis of resting regulatory T cells (rTregs; CD4(+)CD45RA(+)FOXP3(+)) and activated regulatory T cells (actTregs; CD4(+)CD45RA(-)FOXP3(++)) revealed that, although rTregs had low basal, but inducible, Erk activity, actTregs displayed high basal Erk phosphorylation and little or no Akt activation. Interestingly, the use of Mek inhibitors to block Erk activation inhibited activation-dependent FOXP3 upregulation in rTregs, their transition to actTregs, and the resulting increase in suppressive capacity. In summary, our systems approach unraveled distinct differences in signaling elicited by CD28 and CD2 costimulation and between rTregs and actTregs. Blocking rTreg transition to highly suppressive actTregs by Mek inhibitors might have future therapeutic applications.

Download full-text

Full-text

Available from: Kjetil Taskén, Aug 27, 2015
0 Followers
 · 
249 Views
  • Source
    • "Then, TCR as well as other surface receptors and their ligands can stabilize the contact between T cells and APCs, which further triggers the signal transduction pathways resulting in T cell activation (Davis et al., 2003; Smith-Garvin et al., 2009). CD2 is a cell surface glycoprotein expressed on most T cells and natural killer (NK) cells, functioning as a cell adhesion and costimulatory molecule (Kalland et al., 2011; Seed and Aruffo, 1987; Yang et al., 2001). Ligation of CD2 by CD58 in humans or CD48 in rodents helps T cells adhere to APCs, and provides costimulatory signals for T cell activation (Cheadle et al., 2012; Hunig et al., 1987; Latchman and Reiser, 1998; Zhu et al., 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: CD2BP2 (CD2 cytoplasmic tail binding protein 2), one of several proteins interacting with the cytoplasmic tail of CD2, plays a crucial role in CD2-triggered T cell activation and nuclear splicing. The studies on CD2BP2 have tended to be confined to a few mammals, and little information is available to date regarding fish CD2BP2. In this paper, a CD2BP2 gene (On-CD2BP2) was cloned from Nile tilapia, Oreochromis niloticus. Sequence analysis showed the full length of On-CD2BP2 cDNA was 1429bp, containing a 5'untranslated region (UTR) of 111bp, a 3'-UTR of 193bp and an open reading frame of 1025bp which encoding 374 amino acids. Two important structural features, a GYF domain and a consensus motif GPFXXXXMXXWXXXGYF were detected in the deduced amino acid sequence of On-CD2BP2, and the deduced genomic structure of On-CD2BP2 was similar to the known CD2BP2. The mRNA expression of On-CD2BP2 in various tissues of Nile tilapia was analyzed by fluorescent quantitative real-time PCR. In healthy Nile tilapia, the On-CD2BP2 transcripts were mainly detected in head kidney and spleen. While vaccinated with inactivated Streptococcus agalactiae, the On-CD2BP2 mRNA expression was significantly up-regulated in head kidney, spleen and brain respectively 48h post immunization. Moreover, there was a clear time-dependent expression pattern of On-CD2BP2 after immunization and the expression reached the highest level at 24h in brain, 48h in head kidney and spleen, respectively. This is the first report of proving the presence of a CD2BP2 ortholog in fish, and investigating its tissue distribution and expression profile in response to bacteria stimulus. These findings indicated that On-CD2BP2 may play an important role in the immune response to bacteria in Nile tilapia.
    Gene 07/2014; 548(1). DOI:10.1016/j.gene.2014.07.032 · 2.08 Impact Factor
  • Source
    • "negligible suppressive capabilities in these assays ([19] and data not shown). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The C1858T single nucleotide polymorphism in PTPN22, which is the gene encoding lymphoid tyrosine phosphatase (LYP), confers increased risk for various autoimmune disorders in Caucasians. Although the disease-associated LYP allele (LYP∗W620) is a gain-of-function variant that has higher catalytic activity than the major allele (LYP∗R620), it is still unclear how LYP∗W620 predisposes for autoimmunity. Here, we compared both T cell signaling and T cell function in healthy human donors homozygous for either LYP∗R620 or LYP∗W620. Generally, the presence of LYP∗W620 caused reduced proximal T cell antigen receptor-mediated signaling (e.g. ζ chain phosphorylation) but augmented CD28-associated signaling (e.g. AKT activation). Altered ligand binding properties of the two LYP variants could explain these findings since LYP∗R620 interacted more strongly with the p85 subunit of PI3K. Variation in signaling between cells expressing either LYP∗R620 or LYP∗W620 also affected the differentiation of conventional CD4(+) T cells. For example, LYP∗W620 homozygous donors displayed exaggerated Th1 responses (e.g. IFNγ production) and reduced Th17 responses (e.g. IL-17 production). Importantly, while regulatory T cells normally suppressed Th1-mediated IFNγ production in LYP∗R620 homozygous individuals, such suppression was lost in LYP∗W620 homozygous individuals. Altogether, these findings provide a molecular and cellular explanation for the autoimmune phenotype associated with LYP∗W620.
    Human immunology 01/2013; DOI:10.1016/j.humimm.2012.12.017 · 2.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The advancements in proteomics over the past decade have brought tremendous increases in sensitivity of mass spectrometry (MS) analyses and new technologies such as methods for quantitative MS and phosphoproteomics. The development of antibodies targeting a large fraction of the human proteome as well as specific antibodies that detect phosphorylations and other post-translational modifications now allows detection of a great variety of signaling marks. Combined with medium and high throughput methods for detecting many parallel signaling events such as phospho-flow cytometry analyses and MS-based analyses to identify signaling complexes, the available tools now allows analysis of whole signaling networks facilitating systems level understanding of cellular signaling. The even more recent advances in chemical biology and chemical proteomics is further enhancing the development in this area by providing a cache of small molecule compounds allowing perturbations of signal pathways further advancing our global understanding of the signal transduction dynamics at the single cell level as well as in cellular system, tissue and whole organs. This review highlights the recent advances of quantitative MS, phosphoflow cytometry and chemical biology with focus on the dynamic spatiotemporal phosphorylation events, and examples of their application.
    New Biotechnology 01/2013; 30(3). DOI:10.1016/j.nbt.2013.01.003 · 2.11 Impact Factor
Show more